Search the Newsreel

Altimmune stock surges 18% on positive trial results

Altimmune Inc. (NASDAQ:ALT) shares surged 18% after the company announced positive topline results from its RECLAIM Phase 2 trial of pemvidutide for alcohol use disorder. The trial met its primary and key secondary endpoints, showing a statistically significant reduction in heavy drinking days and …

ImmuCell Corp (ICCC) Income Statement

This article provides a detailed quarterly and annual income statement for ImmuCell Corp (ICCC), covering various financial metrics from total revenue to diluted earnings per share. It offers insights into the company's financial performance and operational efficiency over several fiscal years and quarters. The …

1 Popular Cryptocurrency to Buy Before It Soars 13,000%, According to Bitmine's Tom Lee

Cryptocurrencies have had a rough time since October 2025, with most major coins and tokens trading deeply in the red. Not even the industry leaders have escaped the carnage, with Ethereum's native cryptocurrency, Ether (CRYPTO: ETH), down more than 60% from its all-time high. …

Zimmer Biomet Holdings, Inc. $ZBH Shares Bought by First Trust Advisors LP

First Trust Advisors LP increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 23.2% in the first quarter, now owning 387,537 shares valued at over $35 million. Several other hedge funds also adjusted their holdings, with institutional investors collectively owning 88.89% of the …

Gabelli Funds LLC Boosts Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH

Gabelli Funds LLC significantly increased its stake in Zimmer Biomet Holdings, Inc. by 13% in the first quarter, bringing its total holdings to 147,350 shares valued at $13.3 million. Despite a generally cautious analyst outlook, Zimmer Biomet reported strong quarterly earnings, beating estimates with …

Immunic Q1 2026 Earnings: EPS Miss Overshadows Pipeline Progress; Stock Dips 3.4% - Earnings Season Preview

AC Immune (ACIU) Expected to Announce Quarterly Earnings on Tuesday

MindWalk Holdings (Nasdaq: HYFT) readies $250M shelf for AI-driven growth

MoonLake Immunotherapeutics (MLTX) Projected to Release Earnings on Tuesday

Simmons First National (SFNC) Could Be 6% Undervalued As Earnings And Buybacks Land

Immutep Ltd Sponsored ADR Revenue Breakdown – FWB:YP1A

The article provides a financial overview and market data for Immutep Ltd Sponsored ADR (FWB:YP1A) on the Frankfurt Stock Exchange. It highlights the company's financial statements, statistics, dividends, earnings, and segments, indicating a focus on its fundamental performance. No specific revenue breakdown figures are …

Simmons First National Corporation $SFNC Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp reduced its stake in Simmons First National Corporation (SFNC) by 3.9% in the first quarter, selling over 62,000 shares but still holding 1.54 million shares worth approximately $29.9 million. Institutional investors collectively own 27.58% of SFNC, and analysts …

IMMX|Immix Biopharma Inc|Price:8.690|Chg%:+0.170

This article provides detailed market trends and financial analysis for Immix Biopharma Inc (IMMX), including real-time quotes, key figures, and analyst ratings. It highlights that seven analysts currently rate IMMX as "Buy" with a target price of $20.714, representing a 143.13% upside. The company …

Lyell Immunopharma Market Sentiment

This article provides an overview of Lyell Immunopharma's (LYEL) market sentiment, detailing key signals such as analyst consensus, short interest, options flow, and insider activity. Analysts have a "Buy" consensus with a high average price target, while options flow indicates a bearish sentiment with …

ALT|Altimmune Inc|Price:3.030|Chg%:+0.030

Immuron Ltd (IMRN) Cash Flow

This article provides an in-depth look at Immuron Ltd (IMRN) cash flow statements, including operating, investing, and financing cash flows, both quarterly and annually. It highlights the company's negative operating cash flow and free cash flow in the latest fiscal period, alongside explanations of …

Q1 Surgical Equipment & Consumables - Diversified Earnings: Zimmer Biomet (NYSE:ZBH) Earns Top Marks

Q1 Surgical Equipment & Consumables - Diversified Earnings: Zimmer Biomet (NYSE:ZBH) Earns Top Marks As the Q1 earnings season wraps, let's dig into this quarter's best and worst performers in the surgical equipment & consumables - diversified industry, including Zimmer Biomet (NYSE:ZBH) and its …

Lyell Immunopharma, Inc. (LYEL) holder pays broker with 44,000 shares

Innovative Cellular Therapeutics Holdings Ltd, a 10% owner of Lyell Immunopharma, Inc. (LYEL), transferred 44,000 shares of common stock to Wuxiong, Inc. This transfer served as a non-cash broker commission related to a development milestone under a license agreement dated November 6, 2025. Following …

Immunic Inc (IMUX) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Immunic Inc (IMUX), noting its current valuation score of 9.22, which ranks 48 out of 386 in its industry. The company's P/E ratio is reported as -0.95, significantly differing from its recent high and low. Data for …

Bitmine (BMNR) Jumps 13% on More ETH Buy, Ahead of Clarity Act Vote

Bitmine Immersion climbed by 13.49 percent on Monday to finish at $17.92 apiece, after reinforcing its position as one of the market's emerging crypto treasury firms with the recent acquisition of nearly 10,000 Ethereum tokens, while investors positioned ahead of next week's expected passage …

Immatics N.V. (NASDAQ:IMTX) Given Consensus Rating of "Moderate Buy" by Analysts

Eight analysts covering Immatics N.V. (NASDAQ:IMTX) have issued a "Moderate Buy" consensus rating, with six recommending a buy, one a hold, and one a sell. The average 12-month price target is $20.80, significantly above the current $9.08 share price, and institutional investors own 64.41% …

Troluce Capital Advisors LLC Acquires Shares of 250,000 Immatics N.V. $IMTX

Troluce Capital Advisors LLC recently acquired 250,000 shares of Immatics N.V. (NASDAQ:IMTX) for approximately $2.46 million, establishing a new position in the company. Despite Immatics missing Q1 analyst estimates for revenue and EPS, and receiving mixed analyst ratings with some recent downgrades, the consensus …

Altimmune Inc Financials

This article provides a detailed financial summary of Altimmune Inc (ALT), including its latest stock price, market capitalization, and key financial indicators. It presents extensive quarterly and annual data for EPS, Revenue, Net Profit, Balance Sheet items, and Cash Flow, based on reports up …

Altimmune Inc (ALT) Balance Sheet

This article provides detailed balance sheet data for Altimmune Inc (ALT), allowing users to evaluate its financial health through quarterly and annual figures. It includes key financial metrics like cash and short-term investments, total assets, liabilities, and shareholders' equity, along with supporting FAQs. The …

Broker commission transfer of 38,500 shares in Lyell Immunopharma (LYEL)

Innovative Cellular Therapeutics Holdings Ltd, a 10% owner of Lyell Immunopharma (LYEL), transferred 38,500 shares of common stock to LifeSci Advisors, LLC as broker commission on July 27, 2026. This transfer was related to the first Development Milestone payment under a November 6, 2025 …

IMTX|Immatics NV|Price:8.800|

This article from TradingKey provides a comprehensive stock analysis of Immatics NV (IMTX), highlighting its strong fundamentals, significant growth potential, and "fairly valued" status within the Biotechnology & Medical Research industry. It notes high institutional ownership and multiple "Buy" ratings from analysts, despite a …

Immersion Corp earnings beat by $0.21, revenue topped estimates

Immersion Corp (NASDAQ: IMMR) reported strong Q2 earnings, beating analyst estimates with an EPS of $0.300 against a predicted $0.093. The company also surpassed revenue expectations, bringing in $270M compared to the consensus of $230M. Immersion Corp's stock has shown positive performance over the …

AC Immune SA (ACIU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey attempts to provide a revenue breakdown for AC Immune SA (ACIU), covering business segments and regional contributions. However, it explicitly states that the relevant data for these categories has not been disclosed by the company. Therefore, the content primarily highlights …

ICCC|ImmuCell Corp|Price:11.135|Chg%:+0.105

This article provides a comprehensive stock analysis of ImmuCell Corp (ICCC) from TradingKey, highlighting its healthy fundamentals, high growth potential, and a 'fairly valued' assessment within the Pharmaceuticals industry. The analysis notes strong institutional ownership and anticipates an upward trend in the medium term, …

Immuneering Corp (IMRX) Income Statement

Bitmine Added ETH While Strategy's BTC Lull Continues

Two of crypto's biggest corporate treasuries moved in opposite directions last week, as Strategy sat out Bitcoin buying for the 5th week in a row while Bitmine added another chunk of ETH to its stack. What's the Scoop? Strategy's buildup: Its 843,775 BTC holding …

Estrella Immunopharma Inc (ESLA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for Estrella Immunopharma Inc (ESLA). However, it states that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. The page displays basic stock information such as market …

Monday's ETF Movers: IGV, PSI

In trading on Monday, the iShares Expanded Tech-Software Sector ETF is outperforming other ETFs, up about 3.9% on the day. Components of that ETF showing particular strength include shares of Asana, up about 14.2% and shares of Bitmine Immersion Technologies, up about 13% on …

Immunovant Inc (IMVT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Immunovant Inc (IMVT)'s dividend and stock split history. It states that the company has distributed a total of $0.00 in dividends over the past five years, indicating no recent dividend payouts. The page also presents other financial data …

BMNR Stock Climbs As Massive Ethereum Bet Draws Trader Focus

BMNR stock climbed by 12.7% due to strong positive sentiment surrounding BitMine Immersion Technologies Inc.'s massive Ethereum holdings. The company holds approximately 4.8% of the total ETH supply, aiming for 5%, and has staked 4.9M ETH for projected annual staking revenues of $242–$290M. Despite …

How Immunocore Is Expanding Beyond Its Rare-Cancer Drug Kimmtrak

Immunocore Holdings is strategically shifting its focus beyond its single rare-cancer drug, Kimmtrak, leveraging its T-cell receptor platform into broader markets. This expansion includes testing its technology in various solid tumor indications, infectious diseases, and autoimmune conditions. While Kimmtrak remains a commercial success, the …